Accessibility Menu
Relevium Technologies logo

Relevium Technologies(OTC) RLLVF

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Relevium Technologies last closing stock price
MetricPriceDate
Last closeUSD 0.002026-04-24
Relevium Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-01-13
1 month+0%USD 0.002026-01-13
3 month+0%USD 0.002026-01-13
Year to date+0%USD 0.002025-10-10
1 year+0%USD 0.002025-04-04
3 year-90%USD 0.002023-04-12
5 year-100%USD 0.022021-04-23
Since inception-100%USD 0.162017-11-24

Relevium Technologies Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$999.76K

Net Income (TTM)

-CA$6.97M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

2678.61 (High)

Price

$0.00

Volume

2,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

RLLVF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Relevium Technologies

Relevium Technologies Inc. operates in the health and wellness sector, focusing on acquiring and managing various brands primarily through e-commerce channels. The company distributes dietary supplements, nutraceuticals, sports nutrition items, and cosmeceuticals, with notable brands including Bioganix and LeefyLyfe.

Products and Services
  • Dietary supplements under the Bioganix and LeefyLyfe brands
  • Skincare solutions marketed as the Push & Pull System
  • Specialized lines for seniors and children, addressing specific health needs
Growth Outlook
  • Recent quarterly revenue increased to CAD 227,884, showing potential for growth
  • Focus on e-commerce channels aligns with market trends towards online shopping
  • Expansion into specialized health products for seniors and children enhances market reach
Financial Highlights
  • Trailing twelve months (TTM) revenue of CAD 1,227,000 indicates a growing business
  • Gross profit margin improved to 72.36% in the latest quarter
  • Cash and short-term investments totaled CAD 1,970,132, providing liquidity
Relevium Technologies Inc. is positioned within a growing market, capitalizing on the increasing demand for health and wellness products. The company's diverse product offerings and strategic focus on e-commerce provide a solid foundation for future growth. Recent financial performance, including a notable increase in quarterly revenue and improved gross profit margins, reflects the company's potential to capitalize on market opportunities. With a focus on specialized health products, Relevium aims to address the unique needs of various consumer segments, further enhancing its market presence.
AI Generated • Jul 26, 2026

Industry

Personal Products

Headquarters

Montreal, QC H3A 3G4, CA

RLLVF Financials

Key Financial Metrics (TTM)

Gross Margin

45.37%

Operating Margin

-161.49%

Net Income Margin

-587.57%

Return on Equity

221.45%

Return on Capital

N/A

Return on Assets

-707.42%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

2.00K

Avg. Volume

0

Financials (TTM)

Gross Profit

CA$48.16K

Operating Income

-CA$2.82M

EBITDA

-CA$6.39M

Operating Cash Flow

-CA$23.53M

Capital Expenditure

CA$77.58K

Free Cash Flow

-CA$33.45M

Cash & ST Invst.

CA$1.97M

Total Debt

CA$2.61M

Relevium Technologies Performance Analysis

Relevium Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42020-06-30-42.7%
Q12020-09-3010.2%
Q22020-12-31-58.2%
Q32021-03-3164.1%
Relevium Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42020-06-30-60465.8%
Q12020-09-3095.2%
Q22020-12-31-59.9%
Q32021-03-316.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2021YOY CHG

Revenue

CA$227.88K

-56.7%

Gross Profit

CA$164.90K

-60.6%

Gross Margin

72.36%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

-CA$498.26K

-4257.4%

EBITDA

-CA$401.86K

-6206.8%

Quarterly Fundamentals

Name
Q3 2021YOY CHG

Total Cash

CA$1.97M

+10759.6%

Total Debt

CA$2.61M

-12.0%

Accounts Receivable

CA$398.02K

-50.0%

Inventory

CA$115.80K

-56.8%

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$2.61M

-12.0%

Return on Assets

-7.07%

N/A

Return on Invested Capital

30.39%

N/A

Free Cash Flow

-CA$10.00M

-17482.1%

Operating Cash Flow

-CA$77.58K

-36.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MFCSFMedical Facilities Corporation
$11.28-0.44%
CYBQFCYBERDYNE Inc.
$1.31+0.00%
JWCTFJW (Cayman) Therapeutics Co. Ltd
$0.20+0.00%
CLLKFBICO Group AB (publ)
$1.53+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
IBITiShares Bitcoin Trust
$41.20+0.06%
MSTRStrategy
$112.39+0.08%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$46.25-0.02%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$122.21+0.01%

Questions About RLLVF

What is the current price of Relevium Technologies?

Relevium Technologies is trading at $0.00 per share.

What is the 52-week range for Relevium Technologies?

Over the past 52 weeks, Relevium Technologies has traded between $0.00 and $0.00.

How much debt does Relevium Technologies have?

Relevium Technologies total debt is unavailable.

How much cash does Relevium Technologies have on hand?

Relevium Technologies does not have cash on hand data available.

What is Relevium Technologies’s dividend yield?

Relevium Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.